BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 30726835)

  • 1. Sustained Response to Imatinib in a Pediatric Patient with Concurrent Myeloproliferative Disease and Lymphoblastic Lymphoma Associated with a CCDC88C-PDGFRB Fusion Gene.
    Bielorai B; Leitner M; Goldstein G; Mehrian-Shai R; Trakhtenbrot L; Fisher T; Marcu V; Yalon M; Schiby G; Barel O; Cal N; Golan H; Toren A
    Acta Haematol; 2019; 141(2):119-127. PubMed ID: 30726835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel subclonal rearrangement of the STRN3::PDGFRB gene in de novo acute myeloid leukemia with NPM1 mutation and its leukemogenic effects.
    Wang Z; Liu T; Liu W; Gao X; Wan L; Qiu S; Song Y; Gu R; Tian Z; Wang M; Wang J; Mi Y; Wei S
    Cancer Gene Ther; 2023 Nov; 30(11):1471-1484. PubMed ID: 37550570
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Zhang Y; Gao Y; Zhang H; Zhang J; He F; Hnízda A; Qian M; Liu X; Gocho Y; Pui CH; Cheng T; Wang Q; Yang JJ; Zhu X; Liu X
    Blood; 2018 May; 131(20):2256-2261. PubMed ID: 29434033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosine kinase inhibitor response of ABL-class acute lymphoblastic leukemia: the role of kinase type and SH3 domain.
    van Outersterp I; Tasian SK; Reichert CEJ; Boeree A; de Groot-Kruseman HA; Escherich G; Boer JM; den Boer ML
    Blood; 2024 May; 143(21):2178-2189. PubMed ID: 38394665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The novel TERF2::PDGFRB fusion gene enhances tumorigenesis via PDGFRB/STAT5 signalling pathways and sensitivity to TKI in ph-like ALL.
    Xu GF; Zeng Z; Zhang ZB; Zhang XM; Wang M; Xiao Q; Li J; Xie XQ; He S; Fu HH; Liu Y; Yang ZL; Chen Y; Shi J; Wang B; Qiu HY; Zhou Q; Liu Y; Chen SN
    J Cell Mol Med; 2024 Feb; 28(3):e18114. PubMed ID: 38323741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloid/Lymphoid Neoplasms with
    Gou Y; Tang Y; Liu S; Cheng S; Deng X; Wen Q; Feng Y; Peng X; Wang P; Zhang X
    J Inflamm Res; 2023; 16():5163-5170. PubMed ID: 38026242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug sensitivity profiling identifies potential therapies for myeloid neoplasm with eosinophilia driven by a novel G3BP1-PDGFRB fusion gene.
    Wang J; Xu L; Li Y; Wang J; Shao Y; Lai W; Yong J; Zhao L; Wei X; Gao C; Liu D; Gao X; Zhang Y
    Leuk Lymphoma; 2024 Apr; 65(4):521-525. PubMed ID: 38157478
    [No Abstract]   [Full Text] [Related]  

  • 8. False-Negative Testing for FIP1L1::PDGFRA by Fluorescence in situ Hybridization Is a Frequent Cause of Diagnostic Delay.
    Pongdee T; Berry A; Wetzler L; Sun X; Thumm L; Yoon P; Kuang FL; Makiya M; Constantine G; Khoury P; Rheinbay E; Lane AA; Maric I; Klion AD
    Acta Haematol; 2023; 146(4):316-321. PubMed ID: 37285821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting hyperactive platelet-derived growth factor receptor-β signaling in T-cell acute lymphoblastic leukemia and lymphoma.
    De Coninck S; De Smedt R; Lintermans B; Reunes L; Kosasih HJ; Reekmans A; Brown LM; Van Roy N; Palhais B; Roels J; Van der Linden M; Van Dorpe J; Ntziachristos P; Van Delft FW; Mansour MR; Pieters T; Lammens T; De Moerloose B; De Bock CE; Goossens S; Van Vlierberghe P
    Haematologica; 2024 May; 109(5):1373-1384. PubMed ID: 37941480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell phenotype and lack of eosinophilia are not uncommon in extramedullary myeloid/lymphoid neoplasms with ETV6::FLT3 fusion: a case report and review of the literature.
    Schoelinck J; Gervasoni J; Guillermin Y; Beillard E; Pissaloux D; Chassagne-Clement C
    Virchows Arch; 2024 May; 484(5):853-857. PubMed ID: 37985498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloid and lymphoid neoplasm with novel complex translocation: unusual case report with T-lymphoblastic lymphoma, myeloid hyperplasia, eosinophilia, basophilia, and t(1;8;10)( (p31;q24;q11.2).
    Aljabry MS
    J Hematop; 2023 Mar; 16(1):27-31. PubMed ID: 38175368
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Bochicchio MT; Marconi G; Baldazzi C; Bandini L; Ruggieri F; Lucchesi A; Agostinelli C; Sabattini E; Orsatti A; Ferrari A; Capirossi G; Servili C; Ghelli Luserna di Rorà A; Martinelli G; Simonetti G; Rosti G
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203288
    [No Abstract]   [Full Text] [Related]  

  • 13. [Targeted sequencing analysis of hyper-eosinophilic syndrome and chronic eosinophilic leukemia].
    Qu SQ; Qin TJ; Xu ZF; Zhang Y; Jia YJ; Ai XF; Zhang HL; Fang LW; Hu NB; Pan LJ; Li B; Liu JQ; Ru K; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2018 Jun; 39(6):501-506. PubMed ID: 30032569
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of adult acute lymphoblastie leukemia with eosinophilia and abnormality of PDGFRA by autologous hematopoietic stem cell transplantation and imatinib: one case report and literatures review].
    Shi Y; Yang D; Liu Q; He Y; Zhang R; Han M; Feng S
    Zhonghua Xue Ye Xue Za Zhi; 2015 Oct; 36(10):866-7. PubMed ID: 26477768
    [No Abstract]   [Full Text] [Related]  

  • 15. Imatinib and CAR T cell therapy enable sustained response in a young patient with refractory RCSD1-ABL1-positive acute lymphoblastic leukemia.
    Cui Y; Peng H
    Ann Hematol; 2024 Jan; 103(1):361-362. PubMed ID: 37864715
    [No Abstract]   [Full Text] [Related]  

  • 16. Concomitant myeloproliferative neoplasm with eosinophilia, B and T cell lymphoblastic lymphoma/leukemia and mast cell proliferation driven by ZMYM2::FGFR1 rearrangement.
    Loscocco GG; Ascani S; Mannelli F; Zanelli M; Rotunno G; Santi R; Vannucchi AM
    Am J Hematol; 2023 Dec; 98(12):1959-1962. PubMed ID: 37435901
    [No Abstract]   [Full Text] [Related]  

  • 17. Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase fusion genes: A workshop report with focus on novel entities and a literature review including paediatric cases.
    Saft L; Kvasnicka HM; Boudova L; Gianelli U; Lazzi S; Rozman M
    Histopathology; 2023 Dec; 83(6):829-849. PubMed ID: 37551450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoter swapping of truncated PDGFRB drives Ph-like acute lymphoblastic leukemia.
    Miyazaki B; Ueno T; Sugiyama M; Kojima S; Arakawa A; Tao K; Tanimura K; Shiraishi K; Yagishita S; Kohsaka S; Kato M; Kiyokawa N; Goto Y; Yatabe Y; Hamada A; Mano H; Ogawa C; Tanaka Y
    NPJ Precis Oncol; 2023 Dec; 7(1):132. PubMed ID: 38071343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloid/lymphoid neoplasms associated with eosinophilia and rearrangements of
    Zhang L; Zhu X; Qu W; Lu Y; Feng Z; Zhao L
    Haematologica; 2023 Dec; 108(12):3506-3510. PubMed ID: 37102606
    [No Abstract]   [Full Text] [Related]  

  • 20. Fusion of platelet-derived growth factor receptor β to CEV14 gene in chronic myelomonocytic leukemia: A case report and review of the literature.
    Gong SL; Guo MQ; Tang GS; Zhang CL; Qiu HY; Hu XX; Yang JM
    Oncol Lett; 2016 Jan; 11(1):770-774. PubMed ID: 26870282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.